CD59 as a marker of GPI-deficient clone in BM of patients with PNH, MDS, chronic myelogenous leukemia (CML), and normal volunteers. Values shown represent percentages of CD59⁻ cells within the CD34⁺ cell population. Each data point represents a patient tested.